Get the Stockscreener App
0.1347
23.93%
-0.0379
Lunai Bioworks Inc stock is traded at $0.1347, with a volume of 3.11M.
It is down -23.93% in the last 24 hours and down -42.64% over the past month.
Lunai Bioworks Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.
See More
Previous Close:
$0.1726
Open:
$0.1324
24h Volume:
3.11M
Relative Volume:
1.72
Market Cap:
$30.62M
Revenue:
-
Net Income/Loss:
$-67.01M
P/E Ratio:
-0.3962
EPS:
-0.34
Net Cash Flow:
$-8.50M
1W Performance:
-18.80%
1M Performance:
-42.64%
6M Performance:
-80.26%
1Y Performance:
-73.84%
1-Day Range:
$0.13
$0.1354
1-Week Range:
$0.13
$0.192
52-Week Range:
$0.13
$2.10
Lunai Bioworks Inc Stock (RENB) Company Profile
Name
Lunai Bioworks Inc
Sector
Industry
Phone
45 39179840
Address
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
Compare RENB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RENB
Lunai Bioworks Inc
|
0.1326 | 37.73M | 0 | -67.01M | -8.50M | -0.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
382.43 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.43 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.86 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
718.13 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
330.98 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Lunai Bioworks Inc Stock (RENB) Latest News
10M Global Parkinson's Patients: Lunai Bioworks Unveils AI Platform for Novel Treatment Discovery - Stock Titan
Lunai Bioworks To Carry Out 1-for-10 Reverse Stock Split On September 30th, 2025 - 富途牛牛
Lunai Bioworks to Implement 10-for-1 Reverse Stock Split; Shares Slump After Hours - MarketScreener
Lunai Bioworks to implement 10:1 reverse stock split - TipRanks
Lunai Bioworks to effect 10:1 reverse stock split - MSN
Lunai Bioworks stock plunges after announcing 10:1 reverse split By Investing.com - Investing.com UK
Lunai Bioworks stock plunges after announcing 10:1 reverse split - Investing.com
231.7M Shares to Become 23.1M: Lunai Bioworks Implements Major Reverse Stock Split for Nasdaq Listing - Stock Titan
Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split - The Globe and Mail
Stocks Moving Premarket: GLTO, SSKN, QLGN, And Other Gainers & Losers - RTTNews
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery - Gadsden Times
$1.85M NIH Grant Powers Lunai Bioworks' AI Platform to Combat Alcohol Disorder Affecting 19M Americans - Stock Titan
Lunai Bioworks launches transformer-base platform to secure GenAI - The Globe and Mail
Top 3 Health Care Stocks You'll Regret Missing In Q3 - Sahm
REN-B: Lunai Bioworks Unveils AI Platform to Ensure Biological S - GuruFocus
First-Ever AI Safety Platform: Lunai Bioworks Launches Transformer Tech to Secure Drug Discovery & Block Biothreat - Stock Titan
GoodData Acquires Understand Labs, Accelerates AI Data Storytelling and Agentic Vision - Bergen Record
1933 Industries Closes Repurchase and Cancellation of Convertible Debentures - azcentral.com and The Arizona Republic
Lunai Bioworks (RENB) Restructures European Operations for Strat - GuruFocus
Lunai Bioworks Strengthens European Strategy Through Restructuring - PharmiWeb.com
Lunai Bioworks Strengthens European Strategy Through Restructuri - GuruFocus
Lunai Bioworks strengthens European strategy through restructuring - TipRanks
AI Drug Discovery Firm Lunai Bioworks Restructures European Business, Maintains Growth Strategy - Stock Titan
Lunai Bioworks subsidiary Gedi Cube B.V. files for bankruptcy in Amsterdam - Investing.com Australia
Renovaro Biosciences Faces Subsidiary Bankruptcy Impact - TipRanks
Lunai Bioworks subsidiary Gedi Cube B.V. files for bankruptcy in Amsterdam By Investing.com - Investing.com South Africa
Renovaro Inc. shares fall 13.53% after-hours following Lunai Bioworks IncGedi Cube B.V. bankruptcy. - AInvest
Lunai Bioworks IncGedi Cube B.V. Declared Bankrupt By Court Of AmsterdamSEC Filing - TradingView
Lunai partners with defense firm to develop chemical weapons countermeasures - Investing.com Australia
Lunai Bioworks Inc. Retains American Defense International | RENB Stock News - GuruFocus
Lunai Bioworks Inc. Retains American Defense International - PharmiWeb.com
Renovaro BioSciences to change corporate name to ‘Lunai Bioworks’ - MSN
Order flow analysis tools used on Renovaro Inc.July 2025 Selloffs & Verified Entry Point Detection - Newser
Published on: 2025-08-28 20:54:17 - Newser
Applying Elliott Wave Theory to Renovaro Inc.2025 Price Action Summary & Verified Momentum Stock Ideas - Newser
Chart overlay techniques for tracking Renovaro Inc.Weekly Trade Analysis & Risk Controlled Swing Alerts - Newser
Will Renovaro Inc. stock go up soonWeekly Trade Analysis & Fast Moving Stock Trade Plans - Newser
What earnings revisions data tells us about Renovaro Inc.Trade Performance Summary & Growth Focused Entry Point Reports - Newser
Quantitative breakdown of Renovaro Inc. recent moveIPO Watch & Expert Curated Trade Ideas - Newser
Evaluating Renovaro Inc. with trendline analysisJuly 2025 Fed Impact & Stock Portfolio Risk Management - Newser
Applying Wyckoff theory to Renovaro Inc. stockJuly 2025 Drop Watch & Capital Protection Trading Alerts - Newser
Lunai Bioworks Inc Stock (RENB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.20%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):